Psychiatric Co-morbidity in Patients With Irritable Bowel Syndrome at a Tertiary Care Center in Northern India.
- Author:
Yuman KAWOOS
1
;
Zaid A WANI
;
Showkat A KADLA
;
Irfan A SHAH
;
Arshad HUSSAIN
;
M Maqbool DAR
;
Mushtaq A MARGOOB
;
Kouser SIDEEQ
Author Information
- Publication Type:Original Article
- Keywords: Anxiety disorder; Co-morbidity; Depression; Gastrointestinal diseases; Irritable bowel syndrome
- MeSH: Anxiety Disorders; Appointments and Schedules; Case-Control Studies; Depression; Female; Gastroenterology; Gastrointestinal Diseases; Humans; India*; Informed Consent; Irritable Bowel Syndrome*; Male; Outpatients; Tertiary Care Centers*; Tertiary Healthcare*
- From:Journal of Neurogastroenterology and Motility 2017;23(4):555-560
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND/AIMS: Irritable bowel syndrome (IBS) is a chronic psycho-physiological disorder. It is considered to be the most common functional gastrointestinal disorder, and about 50–90% of IBS patients have associated psychiatric co-morbidity. We aimed to study psychiatric co-morbidities in patients with IBS visiting a tertiary care center. METHODS: This was a cross-sectional case-control study conducted over a duration of one and a half years from January 2014 to July 2015. Patients were selected from the out-patient department of gastroenterology. About 160 patients with IBS who fulfilled the inclusion criteria and who gave written informed consent were selected as study cases. The healthy attendants of cases were selected as controls. A total of 200 controls were selected. Rome-III criteria were used to diagnose IBS. For diagnosing psychiatric disorders, we used the Mini International Neuropsychiatric Interview Schedule Plus. RESULTS: Mean age of our cases and controls was 39.7 ± 11.4 and 37.7 ± 9.6 years, respectively. Females outnumbered males in our cases as well as their controls by a ratio of 2:1 approximately. Psychiatric disorders were seen in 84.4% of IBS patients as compared to 41.5% in controls. Major psychiatric disorders seen in our patients were generalized anxiety disorders (30.0%) and depression (28.0%). CONCLUSIONS: The majority of patients with IBS who present to a tertiary care center have co-morbid psychiatric disorders. We need to screen these patients for such co-morbidities and develop a holistic approach for better outcome in such cases.
